Fall 2017 Catalyst Grants for Translational Research Competition Awardees

Please join me in congratulating the successful applicants:

Dr. Samuel Asfaha

Title:

Stem cell markers in metastasis.

Amount Funded:

$25,000 (Translational Metastasis Cancer Research focus)

   

Dr. Muriel Brackstone

Title:

Oncoplastic breast cancer surgery in Ontario.

Amount Funded: $30,000 (Division of Surgical Oncology Award)
   

Dr. Rodney DeKoter

Title:

Identification and characterization of driver mutations in precursor B cell acute lymphoblastic leukemia.

Amount Funded: $22,500 (Translational Leukemia Cancer Research focus)
   

Dr. Jonathan Izawa, Co-Applicants: Drs. Bekim Sadikovic, Khalil Hetou, Erfan Aref-Esghgi

Title:

Development of diagnostic and prognostic epigenomic tools in prostate cancer.

Amount Funded: $25,000 (Translational Prostate Cancer Research focus)
   

Dr. Richard Kim

Title:

Personalizing aromatase inhibitor therapy for breast cancer patients.

Amount Funded: $24,982.50 (Translational Breast Cancer Research focus)
   

Dr. Peeyush Lala, Co-Applicants: Drs. Ted Vandenberg, David Hess

Title:

Validation of EP4 as a therapeutic target in triple negative human breast cancer.

Amount Funded: $25,000 (Translational Breast Cancer Research focus)
   

Dr. Len Luyt, Co-Applicant: Dr. Eva Turley

Title:

The development of drugs interfering with RHAMM-hyaluronan interactions as a novel targeted therapy for aggressive prostate cancer.

Amount

Funded:

$25,000 (Translational Prostate Cancer Research focus)
   

 Dr. Danielle MacNeil, Co-Applicants:  Dr. Amit Garg, 

 Anthony Nichols, Kevin Fung, John Yoo

Title:

Geographic disparities head and neck cancer.

Amount Funded: $29,468 (Division of Surgical Oncology Award)
   

 Dr. Anthony Nichols, Co-Applicant: Dr. Shawn Li

Title:

Informing targeted therapy and immune therapy for HNSCC by functional proteomics.

Amount Funded: $30,000 (Division of Surgical Oncology Award)
   

 Dr. Trevor Shepherd, Co-Applicant: Dr. James Petrik

Title:

Evaluation of dysregulated Mevalonate pathway activity in mutant p53 precursor lesions of ovarian high-grade serous cancer.

Amount Funded: $25,000 (Translational Ovarian Cancer Research focus)

 

Congratulations and well done!

Joe Mymryk, PhD

Chair, Grant Review Panel

LRCP Catalyst Grants for Translational Cancer Research and Training

 

LHSCResearch & Training

Virtual Orientation
LRCP Orientations
For New PatientsFor New Patients Glossary of TermsGlossary of Terms Quick LinksRecommended Sites Contact LRCPContact LRCP Parking, Maps, DirectionsParking, Maps, Directions Upcoming EventsUpcoming Events Canadian Cancer Society Cancer Care Ontario A Cancer Care Ontario Partner
Last Updated December 20, 2017 | © 2007, LHSC, London Ontario Canada